Ironwood Pharmaceuticals Appoints Schulman ’89 to Board
CAMBRIDGE, Mass.—Ironwood Pharmaceuticals, Inc. announced the appointment of Amy Schulman '89 to its board of directors. Schulman is an accomplished leader and entrepreneur with a proven track record of enabling pharmaceutical and biotechnology companies to maximize the value of their brands and realize the potential of their innovations. She currently holds key leadership roles at two biotech companies, serving as chief executive officer and co-founder of Lyndra, Inc., and executive chair of SQZ Biotech. In addition, she is a venture partner at Polaris Partners, serving on the firm’s life sciences investment team.
